PLEKHA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.815400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.776800E-01
Normal-vs-Stage2
9.313000E-01
Normal-vs-Stage3
6.259200E-01
Normal-vs-Stage4
6.291200E-01
Stage1-vs-Stage2
6.899800E-01
Stage1-vs-Stage3
4.089400E-01
Stage1-vs-Stage4
7.908000E-01
Stage2-vs-Stage3
3.416000E-01
Stage2-vs-Stage4
4.687600E-01
Stage3-vs-Stage4
3.568600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.825200E-01
Normal-vs-AfricanAmerican
6.516200E-01
Normal-vs-Asian
9.947800E-01
Caucasian-vs-AfricanAmerican
3.548200E-01
Caucasian-vs-Asian
9.793800E-01
AfricanAmerican-vs-Asian
5.220800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.445200E-01
Normal-vs-Female
9.760200E-01
Male-vs-Female
6.966800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.940200E-01
Normal-vs-Age(41-60Yrs)
6.549200E-01
Normal-vs-Age(61-80Yrs)
8.552200E-01
Normal-vs-Age(81-100Yrs)
6.139800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.702400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.464000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.606400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.873950E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.104400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.992600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.814800E-01
Normal-vs-Daily Drinker
8.814000E-01
Normal-vs-Weekly Drinker
8.766400E-01
Normal-vs-Occasional Drinker
6.541800E-01
Normal-vs-Social Drinker
7.703000E-01
Non Drinker-vs-Daily Drinker
9.570800E-01
Non Drinker-vs-Weekly Drinker
9.681000E-01
Non Drinker-vs-Occasional Drinker
2.150000E-01
Non Drinker-vs-Social Drinker
8.411600E-01
Daily Drinker-vs-Weekly Drinker
9.935000E-01
Daily Drinker-vs-Occasional Drinker
2.671800E-01
Daily Drinker-vs-Social Drinker
9.012000E-01
Weekly Drinker-vs-Occasional Drinker
2.971000E-01
Weekly Drinker-vs-Social Drinker
8.932000E-01
Occasional Drinker-vs-Social Drinker
1.865440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.407600E-02
Normal-vs-Grade 2
5.360200E-03
Normal-vs-Grade 3
1.738930E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.480200E-01
Grade 1-vs-Grade 3
2.087400E-01
Grade 1-vs-Grade 4
2.407600E-02
Grade 2-vs-Grade 3
8.299600E-01
Grade 2-vs-Grade 4
5.360200E-03
Grade 3-vs-Grade 4
1.738930E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.583800E-01
Normal-vs-NonDiabetic
9.876800E-01
Diabetic-vs-NonDiabetic
3.321600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.997600E-01
Normal-vs-NoPancreatitis
9.329000E-01
Pancreatitis-vs-NoPancreatitis
8.697800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.051000E-01
Normal-vs-N1
9.192800E-01
N0-vs-N1
4.383400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.373200E-01
Normal-vs-TP53-NonMutant
9.909400E-01
TP53-Mutant-vs-TP53-NonMutant
6.682400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
